Xcel Wealth Management, LLC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
101 2nd Street Holly Hill, FL 32117
As of the latest 13F report, the guru’s equity portfolio contained 130 stocks valued at a total of $254.00Mil. The top holdings were PFE(5.89%), RH(4.82%), and GOOGL(4.28%).
According to GuruFocus data, these were Xcel Wealth Management, LLC’s top five trades of the quarter.
Verizon Communications Inc
Xcel Wealth Management, LLC reduced their investment in NYSE:VZ by 148,448 shares. The trade had a 2.1% impact on the equity portfolio. During the quarter, the stock traded for an average price of $37.68.
On 01/19/2023, Verizon Communications Inc traded for a price of $40.1339 per share and a market cap of $168.39Bil. The stock has returned -20.43% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Verizon Communications Inc has a price-earnings ratio of 8.70, a price-book ratio of 1.92, a price-earnings-to-growth (PEG) ratio of 3.00, a EV-to-Ebitda ratio of 7.43 and a price-sales ratio of 1.23.
The price-to-GF Value ratio is 0.70, earning the stock a GF Value rank of 10.
Pfizer Inc
Xcel Wealth Management, LLC reduced their investment in NYSE:PFE by 98,969 shares. The trade had a 1.61% impact on the equity portfolio. During the quarter, the stock traded for an average price of $47.94.
On 01/19/2023, Pfizer Inc traded for a price of $45.1215 per share and a market cap of $253.53Bil. The stock has returned -12.54% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Pfizer Inc has a price-earnings ratio of 8.69, a price-book ratio of 2.74, a price-earnings-to-growth (PEG) ratio of 0.83, a EV-to-Ebitda ratio of 6.39 and a price-sales ratio of 2.59.
The price-to-GF Value ratio is 0.52, earning the stock a GF Value rank of 8.
Medtronic PLC
Xcel Wealth Management, LLC reduced their investment in NYSE:MDT by 42,587 shares. The trade had a 1.28% impact on the equity portfolio. During the quarter, the stock traded for an average price of $81.05.
On 01/19/2023, Medtronic PLC traded for a price of $79.715 per share and a market cap of $106.04Bil. The stock has returned -23.58% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Medtronic PLC has a price-earnings ratio of 24.76, a price-book ratio of 2.04, a EV-to-Ebitda ratio of 13.50 and a price-sales ratio of 3.49.
The price-to-GF Value ratio is 0.72, earning the stock a GF Value rank of 10.
Bloomin Brands Inc
Xcel Wealth Management, LLC reduced their investment in NAS:BLMN by 161,730 shares. The trade had a 1.1% impact on the equity portfolio. During the quarter, the stock traded for an average price of $21.66.
On 01/19/2023, Bloomin Brands Inc traded for a price of $23.37 per share and a market cap of $2.05Bil. The stock has returned 17.31% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Bloomin Brands Inc has a price-earnings ratio of 24.80, a price-book ratio of 8.63, a EV-to-Ebitda ratio of 10.86 and a price-sales ratio of 0.53.
The price-to-GF Value ratio is 0.98, earning the stock a GF Value rank of 5.
RH
During the quarter, Xcel Wealth Management, LLC bought 10,160 shares of NYSE:RH for a total holding of 45,829. The trade had a 1.07% impact on the equity portfolio. During the quarter, the stock traded for an average price of $260.61.
On 01/19/2023, RH traded for a price of $295.69 per share and a market cap of $6.82Bil. The stock has returned -28.85% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, RH has a price-earnings ratio of 11.28, a price-book ratio of 5.39, a price-earnings-to-growth (PEG) ratio of 0.19, a EV-to-Ebitda ratio of 11.19 and a price-sales ratio of 2.24.
The price-to-GF Value ratio is 0.69, earning the stock a GF Value rank of 10.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
